J. Prickaerts et al., EFFECTS OF MYOCARDIAL-INFARCTION AND CAPTOPRIL THERAPY ON ANXIETY-RELATED BEHAVIORS IN THE RAT, Physiology & behavior, 60(1), 1996, pp. 43-50
The angiotensin-converting enzyme inhibitor, captopril, is used in the
treatment of heart failure after myocardial infarction. This study ev
aluated whether different behavioral parameters of anxiety are affecte
d by captopril therapy after myocardial infarction in rats. Myocardial
infarction was induced by ligation of the left coronary artery and ca
ptopril therapy was started after 3 weeks. After 2 weeks of captopril
therapy, anxiety-related behaviors were successively measured in four
different tests: open field, elevated plus maze, home cage emergence,
and open field escape. Myocardial infarction and captopril therapy aff
ected behavior in the home cage emergence test and open field escape t
est. On the basis of the data from the open field escape test, captopr
il therapy appeared to decrease anxiety in infarcted rats and increase
anxiety in sham rats. Because myocardial infarction and captopril the
rapy did not affect anxiety-related behaviors in the open field and el
evated plus maze tests, it is assumed that these interventions affect
anxiety-related behaviors depending on the type of test. This was part
ially supported by correlation analysis, which suggested that the beha
vior of the rats in the different tests of anxiety may reflect differe
nt anxiety-related traits.